Medical devices: standardised format for the periodic safety update report

AI Summary

This guidance document, issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA), outlines the necessary standards for manufacturers regarding the compilation of Periodic Safety Update Reports (PSURs). Unlike an inspection report targeting a specific company or identifying violations, this document serves as a high-level regulatory framework designed to assist manufacturers in maintaining post-market safety compliance. The guidance specifies that while comprehensive data is required to ensure drug safety, manufacturers are granted flexibility in report construction. Specifically, sections that are not applicable to the product or relevant to the reporting period may be omitted to streamline the review process. Furthermore, the MHRA allows for data to be presented in alternative formats when such methods are deemed appropriate for the specific data set. In terms of required actions, manufacturers must use this document as a roadmap to ensure that their safety reporting aligns with current UK standards. Although this text does not list specific inspection dates or compliance failures—as it is a general guidance rather than an enforcement action against a particular entity—it establishes the expectations that must be met to avoid future regulatory findings. The emphasis is placed on the accuracy and relevance of the data provided in the interest of ongoing public health and pharmacovigilance.